Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2006-03-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11010-005-9047-9PMID 16532260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.

  2004influential reference
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease.

  2003cited by this paper
• Formula and nomogram for predicting creatinine clearance from serum creatinine concentration

  1997cited by this paper
• Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer.

  1986cited by this paper
• A low molecular weight binding protein for organic anions (Z protein) from human hepatic cytosol: Purification and quantitation

  1981cited by this paper

• Integrating Novel Biomarkers into Clinical Practice: A Practical Framework for Diagnosis and Management of Cardiorenal Syndrome

  2025cites this paper
• Fetuin-A and Heme Oxygenase 1 as Potential New Markers in the Diagnosis of Diabetic Kidney Disease

  2025influential citation
• Biosensor Innovations for Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD) Diagnostics.

  2025cites this paper
• Biomarkers in diabetic nephropathy: A comprehensive review of their role in early detection and disease progression monitoring.

  2025cites this paper
• Acute Kidney Injury Biomarkers in Marathon Runners: Systematic Review and Meta-Analysis

  2025cites this paper
• Slot Blot- and Electrospray Ionization–Mass Spectrometry/Matrix-Assisted Laser Desorption/Ionization–Mass Spectrometry-Based Novel Analysis Methods for the Identification and Quantification of Advanced Glycation End-Products in the Urine

  2024cites this paper
• Urinary biomarkers in kidney disease.

  2024cites this paper
• An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies.

  2024cites this paper
• Biomarkers of chronic kidney disease in older individuals: navigating complexity in diagnosis

  2024cites this paper
• Combining robust urine biomarkers to assess chronic kidney disease progression

  2023cites this paper
• Acute Kidney Injury Is Associated with Higher Serum Cys-C and NGAL Concentrations, and Risk of Mortality in Premature Calves with Respiratory Distress Syndrome

  2023cites this paper
• Protein Biomarkers in Chronic Kidney Disease in Children—What Do We Know So Far?

  2023cites this paper
• Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease

  2023cites this paper
• Aktuelles zu diagnostischen und prognostischen Biomarkern einer diabetischen Nephropathie

  2023cites this paper
• Update on prognosis driven classification of pediatric AKI

  2022cites this paper
• PREDICTIVE MARKERS IN CHRONIC KIDNEY DISEASE.

  2022cites this paper
• Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives

  2022influential citation
• The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft

  2022influential citation
• Xanthine Oxidoreductase Activity in Marathon Runners: Potential Implications for Marathon-Induced Acute Kidney Injury.

  2022cites this paper
• Renal biomarkers in cats: A review of the current status in chronic kidney disease

  2022cites this paper
• Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury

  2021cites this paper
• Significance of urinary liver-type fatty acid-binding protein in patients with normal renal function after undergoing intestinal urinary diversion: a preliminary study

  2021influential citation
• Urinary concentrations of neonicotinoid insecticides were related to renal tubular dysfunction and neuropsychological complaints in Dry-zone of Sri Lanka

  2021cites this paper
• Urinary Concentrations of Neonicotinoid Insecticides and Tubular Biomarkers, and Clinical Symptoms in Chronic Kidney Disease Patients, Their Family Members and Others in Dry-zone of Sri Lanka: a Small Scale Field-based Case-Control Study

  2021cites this paper
• The Role of Elevated Liver-Type Fatty Acid-Binding Proteins in Liver Diseases

  2021cites this paper
• Liver‐type fatty acid‐binding protein and neutrophil gelatinase‐associated lipocalin in cats with chronic kidney disease and hyperthyroidism

  2021influential citation
• Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.

  2021cites this paper
• Medical physiological parameter for lead/vaccine testing

  2021cites this paper
• Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes

  2021cites this paper
• Biomarkers in Pediatric Cardiology and Cardiac Surgery

  2020cites this paper
• Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis

  2020cites this paper
• Molecular basis of kidney disease

  2020cites this paper
• Novel Urinary Biomarkers and Chronic Kidney Disease After Coronary Angiography: A Prospective Case-Controlled Study

  2020cites this paper
• Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease

  2020influential citation
• Durable response without recurrence to Tolvaptan improves long-term survival

  2020cites this paper
• Adipocyte Fatty Acid-Binding Protein as a Predictor of Outcome in Alcohol-induced Acute-On-Chronic Liver Failure.

  2020cites this paper
• Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values

  2019cites this paper
• Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients

  2019cites this paper
• Biomarkers of Acute and Chronic Kidney Disease.

  2019cites this paper
• Kidney-based in vitro models for drug-induced toxicity testing

  2019cites this paper
• Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases

  2019cites this paper
• Sensitive and specific detection of proteins based on target-responsive DNA polymerase activity.

  2019cites this paper
• Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma

  2019cites this paper
• Tubular and Glomerular Biomarkers of Acute Kidney Injury in Newborns.

  2019cites this paper
• 7 Arterial Hypertension and Renal Disease

  2018cites this paper
• L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome.

  2018cites this paper
• Renal Impairment in Chronic Hepatitis B: A Review

  2018cites this paper
• Urinary Liver Type Fatty Acid Binding Protein Is Negatively Associated With Estimated Glomerular Filtration Rate in Renal Transplant Recipients With Graft Loss.

  2018cites this paper
• Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease

  2018cites this paper
• Arsenic, cadmium, lead, and chromium in well water, rice, and human urine in Sri Lanka in relation to chronic kidney disease of unknown etiology.

  2018cites this paper
• Chapter Four – The Role of Proteomics in the Study of Kidney Diseases and in the Development of Diagnostic Tools

  2017cites this paper
• Biomarkers in acute kidney injury (AKI).

  2017cites this paper
• Chapter One – Characteristics of an Ideal Biomarker of Kidney Diseases

  2017cites this paper
• Liver fatty acid binding protein protects renal function through down-regulation of oxidative stress in IgA nephropathy

  2017cites this paper
• Biomarkers for Early Detection of Acute Kidney Injury.

  2017cites this paper
• Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4

  2017cites this paper
• Predicting acute kidney injury: current status and future challenges

  2017cites this paper
• Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease

  2016cites this paper
• Assessing and Predicting Drug‐Induced Kidney Injury, Functional Change, and Safety in Preclinical Studies in Rats

  2016cites this paper
• Messung von Biomarkern der Nierenschädigung in Serum und Urin von Patienten nach Nierentransplantation

  2016influential citation
• Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure

  2016cites this paper
• PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY.

  2016cites this paper
• Urinary Markers of Tubular Injury in Early Diabetic Nephropathy

  2016cites this paper
• Early Biomarkers of Renal Damage in Relation to Arterial Stiffness and Inflammation in Male Coronary Artery Disease Patients

  2016cites this paper
• Early Predictors of Acute Kidney Injury: A Narrative Review

  2016cites this paper
• Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6

  2016cites this paper
• Impact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein

  2016cites this paper
• DCoH: A novel biomarker for diagnosing acute kidney injury.

  2016cites this paper
• Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.

  2016cites this paper
• Urinary kidney injury molecules in children with febrile seizures

  2016cites this paper
• EVALUATION OF MONOCYTE CHEMOTACTIC PROTEIN (MCP-1) IN SALIVA AS AN EARLY SIGN OF METABOLIC DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

  2016cites this paper
• Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD

  2016cites this paper
• Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?

  2016cites this paper
• Follow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI).

  2016cites this paper
• The Role of Novel Cardiorenal Biomarkers in the Cardiac Catheterization Laboratory for the Detection of Acute Kidney Injury.

  2016cites this paper
• FABP1 and FABP3 Have High Predictive Values for Renal Replacement Therapy in Patients with Acute Kidney Injury

  2016cites this paper
• The Kidney in Critical Cardiac Disease

  2016cites this paper
• Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia

  2015cites this paper
• Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia

  2015cites this paper
• Urinary L‐FABP as a mortality predictor in <5‐year‐old children with sepsis in Bangladesh

  2015cites this paper
• Biomarkers of Renal Disease and Progression in Patients with Diabetes

  2015influential citation
• The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse

  2015cites this paper
• Urinary early kidney injury molecules in children with beta-thalassemia major

  2015cites this paper
• Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients

  2015cites this paper
• I-FABP and L-FABP are early markers for abdominal injury with limited prognostic value for secondary organ failures in the post-traumatic course

  2015cites this paper
• The biomarker for CKD: urinary L-FABP - from molecular function to clinical significance.

  2015cites this paper
• Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2

  2015cites this paper
• Urinary excretion of liver-type FABP as a new clinical marker for the progression of obstructive nephropathy.

  2014cites this paper
• Studies on Pediatric Disorders

  2014cites this paper
• Urine liver-type fatty acid-binding protein predicts graft outcome up to 2 years after kidney transplantation.

  2014cites this paper
• Preventing the Progression of Diabetic Kidney Disease

  2014cites this paper
• Serum liver‐type fatty acid‐binding protein predicts recovery of graft function after kidney transplantation from donors after cardiac death

  2014cites this paper
• Limitations of Conventional Parameters and Role of Urinary Protein Biomarkers in the Determination of Drug Induced Acute Kidney Injury in Very Early Stage

  2014influential citation
• Urinary L-Type Fatty Acid-Binding Protein as a New Renal Biomarker

  2014cites this paper
• Low levels of urinary liver-type fatty acid-binding protein may indicate a lack of kidney protection during aortic arch surgery requiring hypothermic circulatory arrest.

  2014cites this paper
• Biomarkers of acute kidney injury in neonatal encephalopathy

  2013cites this paper
• Urine neutrophil gelatinase-associated lipocalin predicts graft outcome up to 1 year after kidney transplantation.

  2013cites this paper
• Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes

  2013cites this paper
• The Role of Urinary Liver-Type Fatty Acid-Binding Protein in Critically Ill Patients

  2013cites this paper
• Biomarkers of acute kidney injury.

  2013cites this paper